Mallika Singh

Mallika Singh is an accomplished biotechnology professional with extensive experience in cancer pharmacology and translational research. Currently serving as Vice President of Translational Research at REVOLUTION Medicines since May 2017, Mallika Singh previously held roles including Senior Director and Director in cancer pharmacology. Prior experience includes leadership positions at ORIC Pharmaceuticals and Patronus Therapeutics, where Mallika Singh co-founded a startup and led its scientific strategy. Earlier career stages involved significant contributions to oncology drug development at Novartis Institutes for BioMedical Research, Genentech, Exelixis, and academic research at the University of California, San Francisco, and the University of Utah. Mallika Singh holds a Ph.D. in Biochemistry from the University of Utah and a B.S. in Chemistry from St. Stephen's College, Delhi.